Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20596
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Daskalopoulos, G. N. | en |
dc.contributor.author | Karkanaki, A. | en |
dc.contributor.author | Karagiannis, A. | en |
dc.contributor.author | Mikhailidis, D. P. | en |
dc.contributor.author | Athyros, V. G. | en |
dc.date.accessioned | 2015-11-24T19:08:48Z | - |
dc.date.available | 2015-11-24T19:08:48Z | - |
dc.identifier.issn | 1940-1574 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20596 | - |
dc.rights | Default Licence | - |
dc.subject | Cardiovascular Diseases/*etiology/metabolism/prevention & control | en |
dc.subject | Diabetes Mellitus, Type 2/etiology/metabolism/prevention & control | en |
dc.subject | Dyslipidemias/etiology/metabolism/prevention & control | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Phenotype | en |
dc.subject | Polycystic Ovary Syndrome/*complications/metabolism | en |
dc.subject | Risk Factors | en |
dc.title | Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome? | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | 10.1177/0003319711399571 | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21474465 | - |
heal.identifier.secondary | http://ang.sagepub.com/content/62/4/285.full.pdf | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.publicationDate | 2011 | - |
heal.abstract | Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age, affecting around 10% of them. Polycystic ovary syndrome is considered to be related to increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). There are 2 definitions for PCOS: one adopted in 1990 (classical PCOS with phenotypes A and B) and the other in 2003 (Rotterdam criteria with 4 phenotypes A to D). The latter is a wider definition including the 1990 phenotypes. There is mounting data suggesting that phenotypes C and D are not actually related to increased CVD risk, and thus screening for CVD risk factors of intervening for primary CVD prevention in young women is not cost-effective. There is an increasing number of suggestions to return to the 1990 criteria plus some metabolic parameters to identify real CVD risk in this population. However, such a strategy needs verification by large, prospective studies. | en |
heal.journalName | Angiology | en |
heal.journalType | peer-reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Daskalopoulos-2011-Is the risk for card.pdf | 147.79 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License